ArticleUrology research & practice2026
Pure Ultrasound with Two-Step Dilation vs. Combined Ultrasound-Fluoroscopy in Percutaneous Nephrolithotomy: Is Fluoroscopy Still Needed?
Article in Urology research & practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFluoroscopy has been the most widely used guidance method for percutaneous nephrolithotomy (PCNL); however, radiation exposure is a significant concern. Recently, ultrasound has gained popularity, offering several advantages. The objective was to evaluate the safety and outcomes of the pure-ultrasound PCNL with a two-step tract dilation. MATERIAL AND
methodsThe authors retrospectively analyzed the data of patients from March 2019 to October 2023. In all patients, percutaneous renal access was ultrasound guided, and they were divided into 2 groups: Group 1, all steps of PCNL were performed under ultrasound guidance, and Group 2, tract dilation, confirmation of stone clearance, and exit strategy were done with fluoroscopy.
resultsThe authors included 100 patients, 60 in Group 1 and 40 in Group 2, with a mean body mass index of 30.8 kg/m2. Mean stone burden was 4,162 mm3, 53% were complex stones and 59% of the cases were without hydronephrosis in the targeted calyx. Fluoroscopy was absent in Group 1 and 20 (11.3-31.5) seconds in Group 2 (P < .001). Complications were present in 13% of the cases. Group 1 patients had a lower complication rate than those in Group 2 (10% and 17%, respectively, P = .27). The authors had a global stone-free rate of 79%, Group 1: 78.3% and Group 2: 80% (P = 1.0). Multivariate analysis revealed that the stone-free rate is associated with the total operative time (P = .002) and the number of tracts (P = .031).
conclusionPure ultrasound PCNL is a safe and effective technique, offering a similar stone-free rate compared to fluoroscopy and providing an alternative method to avoid radiation exposure during PCNL. Cite this article as: Pulido-Contreras E, Garcia-Padilla MA, Rios-Melgarejo C, Medrano-Sanchez J, Leon-Verdin MG, Sur RL. Pure ultrasound with two-step dilation vs. combined ultrasoundfluoroscopy in percutaneous nephrolithotomy: Is fluoroscopy still needed? Urol Res Pract. 2025;51(6):217-224.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.